# The Effect of Nicorandil on Rheumatoid Arthritis Patients

> **NCT07730723** · PHASE2,PHASE3 · RECRUITING · sponsor: **Ain Shams University** · enrollment: 70 (estimated)

## Conditions studied

- Rheumatoid Arthritis (RA)

## Interventions

- **DRUG:** Nicorandil Oral Tablet
- **DRUG:** Placebo
- **DRUG:** conventional synthetic antirheumatic drugs (cDMARDs)

## Key facts

- **NCT ID:** NCT07730723
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-06
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07730723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07730723, "The Effect of Nicorandil on Rheumatoid Arthritis Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07730723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*